RT Journal Article
SR Electronic
T1 SARS-CoV-2 On-the-Spot Virus Detection Directly from Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.22.20072389
DO 10.1101/2020.04.22.20072389
A1 Nadav Ben-Assa
A1 Rawi Naddaf
A1 Tal Gefen
A1 Tal Capucha
A1 Haitham Hajjo
A1 Noa Mandelbaum
A1 Lilach Elbaum
A1 Peter Rogov
A1 King A. Daniel
A1 Shai Kaplan
A1 Assaf Rotem
A1 Michal Chowers
A1 Moran Szwarcwort-Cohen
A1 Mical Paul
A1 Naama Geva-Zatorsky
YR 2020
UL http://medrxiv.org/content/early/2020/05/07/2020.04.22.20072389.abstract
AB Many countries are currently in a lockdown state due to the SARS-CoV-2 pandemic. One key aspect to transition safely out of lockdown is to continuously test the population for infected subjects. Currently, detection is performed at points of care using quantitative reverse-transcription PCR (RT-qPCR), and requires dedicated professionals and equipment. Here, we developed a protocol based on Reverse Transcribed Loop-Mediated Isothermal Amplification (RT-LAMP) for detection of SARS-CoV-2. This protocol is applied directly on SARS-CoV-2 nose and throat swabs, with no RNA purification step required. We tested this protocol on over 180 suspected patients, and compared its results to the standard method. We further succeeded to apply the protocol on self-sampled saliva from confirmed cases. Since the proposed protocol provides results on-the-spot, and can detect SARS-CoV-2 from saliva, it can allow simple and continuous surveillance of the community.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Technion Integrated Cancer Center, the Technion — Israel Institute of Technology, “Keren Hanasi” Alon Fellowship for Outstanding Young Researchers, Horev Fellow (Taub Foundation). HH is supported by the Leonard and Diane Sherman Interdisciplinary Graduate School Fellowship. NGZ is an Azrieli Global Scholar at the Canadian Institute for advanced research (CIFAR).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available.